Why Kalydeco is the FDA's biggest approval of 2012

12/26/2012 | Forbes

Of the 40 new drug approvals by the FDA this year, one stands out above the rest, Matthew Herper writes. The Cystic Fibrosis Foundation played a pivotal role in the development of Vertex's cystic fibrosis treatment Kalydeco, which directly acts on a gene that can cause cystic fibrosis, and groups such as the Michael J. Fox Foundation, the Multiple Myeloma Research Foundation and Myelin Repair are playing similar roles in drug development.

View Full Article in:

Forbes

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Chief Quality Officer
UnityPoint Clinic
Des Moines, ID
Director, Payer Marketing
Avalere Health
Washington, DC
The Pew Charitable Trusts
Director, Antibiotics and Innovation Project
Washington, DC
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX